Zanuttigh, E. et al. Identification of autophagy as a functional target suitable for the pharmacological treatment of mitochondrial membrane protein-associated neurodegeneration (MPAN) in vitro. Pharmaceutics 15:19 (2023)
Heine, S. et al. Thermosensitive PLGA-PEG-PLGA hydrogel as depot matrix for allergen-specific immunotherapy. Pharmaceutics 14:1527 (2022)
Keutzer, L.* et al. Machine learning and pharmacometrics for prediction of pharmacokinetic data: Differences, similarities and challenges illustrated with rifampicin. Pharmaceutics 14:1530 (2022)
Kyrkou, S.G.* et al. Design principles governing the development of theranostic anticancer agents and their nanoformulations with photoacoustic properties. Pharmaceutics 14:362 (2022)
Santiago Franco, M. & Youn, Y.S.* Delivery of molecules using nanoscale systems for cancer treatment and/or diagnosis. Pharmaceutics 14:851 (2022)
Secher, T.* et al. Aggregates associated with instability of antibodies during aerosolization induce adverse immunological effects. Pharmaceutics 14:671 (2022)
Wu, M.* et al. Continuous NPWT regulates fibrosis in murine diabetic wound healing. Pharmaceutics 14:2125 (2022)
Efremova, M.V. et al. Genetically encoded self-assembling iron oxide nanoparticles as a possible platform for cancer-cell tracking. Pharmaceutics 13:397 (2021)